FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but not after Medical Management in Patients with Type 2 Diabetes

PURPOSE: To quantify changes in fibroblast growth factor 19 (FGF19) and bile acids (BAs) in patients with uncontrolled type 2 diabetes randomized to Roux-en-Y gastric bypass (RYGB) vs intensive medical management (IMM) and matched for similar reduction in HbA1c after 1 year of treatment. MATERIALS A...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Obes Surg
Prif Awduron: Sachdev, Saachi, Wang, Qi, Billington, Charles, Connett, John, Ahmed, Leaque, Inabnet, William, Chua, Streamson, Ikramuddin, Sayeed, Korner, Judith
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4751075/
https://ncbi.nlm.nih.gov/pubmed/26259981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11695-015-1834-0
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg